M Mrázek

640 total citations
11 papers, 264 citations indexed

About

M Mrázek is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, M Mrázek has authored 11 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 6 papers in Reproductive Medicine and 5 papers in Molecular Biology. Recurrent topics in M Mrázek's work include Reproductive Biology and Fertility (7 papers), Ovarian function and disorders (4 papers) and Assisted Reproductive Technology and Twin Pregnancy (4 papers). M Mrázek is often cited by papers focused on Reproductive Biology and Fertility (7 papers), Ovarian function and disorders (4 papers) and Assisted Reproductive Technology and Twin Pregnancy (4 papers). M Mrázek collaborates with scholars based in Czechia, Denmark and Spain. M Mrázek's co-authors include J. Fulka, Josef Fulka, Pasqualino Loi, Fatima Elzeinová, Jana Pěknicová, Carlos Simón, Claire Bourgain, Roger A. Pierson, Sanja Kupešić and Wendy Dean and has published in prestigious journals such as Human Reproduction, Fertility and Sterility and Reproduction.

In The Last Decade

M Mrázek

9 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Mrázek Czechia 5 201 129 84 66 58 11 264
Ludmila Voložonoka Latvia 6 117 0.6× 86 0.7× 55 0.7× 112 1.7× 137 2.4× 10 241
Brittany L. Daughtry United States 7 121 0.6× 122 0.9× 103 1.2× 47 0.7× 56 1.0× 10 242
Tailai Chen China 9 147 0.7× 227 1.8× 68 0.8× 121 1.8× 89 1.5× 14 306
Xiaozhen Liu China 10 187 0.9× 52 0.4× 71 0.8× 37 0.6× 57 1.0× 29 275
A Pujol Spain 7 95 0.5× 141 1.1× 123 1.5× 105 1.6× 73 1.3× 15 269
Marc Peter Maserati United States 8 131 0.7× 174 1.3× 35 0.4× 97 1.5× 67 1.2× 15 274
Sachiko Makabe Italy 7 172 0.9× 201 1.6× 82 1.0× 121 1.8× 24 0.4× 15 321
Ann Marie Paprocki United States 8 210 1.0× 301 2.3× 60 0.7× 185 2.8× 65 1.1× 14 401
Lynette Wilson United Kingdom 5 141 0.7× 182 1.4× 82 1.0× 89 1.3× 44 0.8× 6 268

Countries citing papers authored by M Mrázek

Since Specialization
Citations

This map shows the geographic impact of M Mrázek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mrázek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mrázek more than expected).

Fields of papers citing papers by M Mrázek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mrázek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mrázek. The network helps show where M Mrázek may publish in the future.

Co-authorship network of co-authors of M Mrázek

This figure shows the co-authorship network connecting the top 25 collaborators of M Mrázek. A scholar is included among the top collaborators of M Mrázek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mrázek. M Mrázek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Pierson, Roger A., et al.. (2012). Effects of barusiban, a selective oxytocin antagonist, on uterine contractility in the luteal phase after controlled ovarian stimulation. Fertility and Sterility. 98(3). S183–S183. 2 indexed citations
3.
García-Velasco, Juan A., Sanja Kupešić, António Pellicer, et al.. (2011). Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial. Reproductive BioMedicine Online. 24(2). 153–162. 4 indexed citations
4.
García-Velasco, Juan A., Sanja Kupešić, M Mrázek, et al.. (2008). Synchronisation of the follicle cohort with the GnRH antagonist degarelix: a randomised, assessor-blind, placebo-controlled trial. Fertility and Sterility. 90. S234–S234.
5.
Pěknicová, Jana, et al.. (2006). Evaluation of reproductive potential after intracytoplasmic sperm injection of varied human semen tested by antiacrosomal antibodies. Fertility and Sterility. 86(1). 113–120. 11 indexed citations
6.
Fulka, J., M Mrázek, & Pasqualino Loi. (2005). Mammalian Oocyte Therapies. Cloning and Stem Cells. 7(3). 183–188. 13 indexed citations
7.
Fulka, J. & M Mrázek. (2004). [Cloning of mammals--biological aspects].. PubMed. 143(5). 295–8. 2 indexed citations
8.
Fulka, J., et al.. (2004). DNA methylation pattern in human zygotes and developing embryos. Reproduction. 128(6). 703–708. 176 indexed citations
9.
Mrázek, M. (2003). Failure of oocyte maturation: Possible mechanisms for oocyte maturation arrest. Human Reproduction. 18(11). 2249–2252. 45 indexed citations
10.
Fulka, J., et al.. (2002). Nucleus Replacement in Mammalian Oocytes. Cloning and Stem Cells. 4(3). 181–187. 8 indexed citations
11.
Lachman, M, et al.. (1998). [MESA, TESA, TESE + ICSI: results of the first 50 cases].. PubMed. 63(1). 13–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026